Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1987-7-15
pubmed:abstractText
We examined the clonality of tumors induced by an acutely transforming retrovirus which carries a single oncogene. Contrary to our expectation, tumors induced by the Abelson murine leukemia virus (A-MuLV) showed one to four major proviral integration events. To further investigate the process by which clonality was established, we analyzed the number of cells infected and transformed by A-MuLV at various times after in vivo infection. At the midpoint of tumor latency (14 days postinfection), we found that infection of total bone marrow cells by A-MuLV was efficient and polyclonal. However, only a minority of these infected cells were transformed as assayed in cell culture, and clonal dominance had already been established in this transformed cell population. Examination of the in vitro growth properties of transformed cells recovered from preleukemic and leukemic mice indicated that preleukemic cells had lower cloning efficiencies than primary tumor cells. Our results suggest that the rate-limiting step in this system of lymphomagenesis is the initial transformation of bone marrow target cells and that these cells undergo subsequent changes in cloning ability during the course of the disease that lead to an autonomous neoplastic state.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-1195397, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-163444, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-168584, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-178822, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-197258, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-229975, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-2856928, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-3906410, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-4099080, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-6122701, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-6257398, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-6257926, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-6264461, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-6275106, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-6277505, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-6287020, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-6294342, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-6304498, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-6304726, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-6319018, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-6608556, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-6980414, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-702054, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-7155168, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-7432471, http://linkedlifedata.com/resource/pubmed/commentcorrection/3035219-9279386
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
61
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2192-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1987
pubmed:articleTitle
Clonal dominance and progression in Abelson murine leukemia virus lymphomagenesis.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.